Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

CELLPRO TO EXPAND CEPRATE TRIALS

Nov. 20, 1991

STOCKS REBOUND, BUT MAY HAVE PEAKED

Nov. 19, 1991

CENTOCOR TO CO-DEVELOP MAbs WITH CORVAS

Nov. 19, 1991

NOVEN GRANTS DELIVERY SYSTEM RIGHTS

Nov. 19, 1991

AURICULIN HELPS PREVENT KIDNEY TOXICITY

Nov. 19, 1991

EARLY SUCCESS WITH OVARIAN CANCER DRUG

Nov. 19, 1991

SCHERING SUES STERLING OVER IL-4

Nov. 19, 1991

PROTEIN DEVICE TO REPAIR FRACTURES

Nov. 19, 1991

GENZYME'S r-GCR GETS ORPHAN DESIGNATION

Nov. 19, 1991

MICROPROBE RAISES $2.9 MILLION

Nov. 19, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.